Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Update crawled date : 2022 - 07 - 29 save search
Entourage Health Provides Update on Credit Facilities’ Maturity Dates and Amends Outstanding Unsecured Convertible Debentures
Published: 2022-07-29 (Crawled : 23:00) - globenewswire.com
BMO | $92.84 -1.05% 0.0% 350K
|
Finance
| Email alert
Add to watchlist
health update
Evaxion Biotech to Host Q2 2022 Corporate Update Conference Call & Webcast on August 10
Published: 2022-07-29 (Crawled : 22:00) - globenewswire.com
EVAX | $4.06 -1.93% -1.97% 10K
|
Manufacturing
| Email alert
Add to watchlist
conference biotech update
Q BioMed Inc. Provides Update to Shareholders
Published: 2022-07-29 (Crawled : 15:00) - biospace.com/
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: -9.36%
H: 0.65%
C: -35.61%
update
Salarius Pharmaceuticals to Host Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 8, 2022
Published: 2022-07-29 (Crawled : 13:20) - globenewswire.com
SLRX | $0.501 1.18% 19K
|
Commercial Services
|
| O: 3.95%
H: 5.05%
C: -4.9%
conference update results
Bristol Myers Squibb Provides Update on CheckMate -914 Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) as Adjuvant Treatment of Localized Renal Cell Carcinoma
Published: 2022-07-29 (Crawled : 12:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.33%
H: 0.27%
C: -0.9%
treatment opdivo renal trial plus update cell carcinoma nivolumab
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19Interim DSMB review expected in late September
Published: 2022-07-29 (Crawled : 12:00) - biospace.com/
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 0.94%
H: 4.9%
C: 3.4%
covid-19 treatment expected review update study
Forma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022
Published: 2022-07-29 (Crawled : 12:00) - biospace.com/
FMTX | $20.01 -0.15%
|
Health Technology
|
| O: 2.31%
H: 2.25%
C: -1.78%
report therapeutics update results
Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-07-29 (Crawled : 12:00) - biospace.com/
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: -1.63%
H: 1.98%
C: -3.21%
report update results
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
Published: 2022-07-29 (Crawled : 12:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 0.94%
H: 4.9%
C: 3.4%
covid-19 treatment update study
Verona Pharma to Report Second Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-07-29 (Crawled : 07:00) - biospace.com/
VRNA | $15.21 -2.44% -2.5% 320K
|
Health Technology
|
| O: -0.36%
H: 1.83%
C: -1.47%
pharma report update results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.